Literature DB >> 1662118

RXR beta: a coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements.

V C Yu1, C Delsert, B Andersen, J M Holloway, O V Devary, A M Näär, S Y Kim, J M Boutin, C K Glass, M G Rosenfeld.   

Abstract

The retinoic acid receptor (RAR) requires coregulators to bind effectively to response elements in target genes. A strategy of sequential screening of expression libraries with a retinoic acid response element and RAR identified a cDNA encoding a coregulator highly related to RXR alpha. This protein, termed RXR beta, forms heterodimers with RAR, preferentially increasing its DNA binding and transcriptional activity on promoters containing retinoic acid, but not thyroid hormone or vitamin D, response elements. Remarkably, RXR beta also heterodimerizes with the thyroid hormone and vitamin D receptors, increasing both DNA binding and transcriptional function on their respective response elements. RXR alpha also forms heterodimers with these receptors. These observations suggest that retinoid X receptors meet the criteria for biochemically characterized cellular coregulators and serve to selectively target the high affinity binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate DNA response elements.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662118     DOI: 10.1016/0092-8674(91)90301-e

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  274 in total

1.  Structure of the RXR-RAR DNA-binding complex on the retinoic acid response element DR1.

Authors:  F Rastinejad; T Wagner; Q Zhao; S Khorasanizadeh
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

2.  p300 requires its histone acetyltransferase activity and SRC-1 interaction domain to facilitate thyroid hormone receptor activation in chromatin.

Authors:  J Li; B W O'Malley; J Wong
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  Probing protein oligomerization in living cells with fluorescence fluctuation spectroscopy.

Authors:  Yan Chen; Li-Na Wei; Joachim D Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

4.  Terminal differentiation in keratinocytes involves positive as well as negative regulation by retinoic acid receptors and retinoid X receptors at retinoid response elements.

Authors:  B J Aneskievich; E Fuchs
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

5.  Ligand-dependent conformational changes in the progesterone receptor are necessary for events that follow DNA binding.

Authors:  G F Allan; S Y Tsai; M J Tsai; B W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

6.  Isolation of a full-length cDNA clone encoding a N-terminally variant form of the human retinoid X receptor beta.

Authors:  K Fleischhauer; J H Park; J P DiSanto; M Marks; K Ozato; S Y Yang
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

7.  Screening for ligands of human retinoid X receptor-alpha using ultrafiltration mass spectrometry.

Authors:  Dongting Liu; Jian Guo; Yan Luo; David J Broderick; Michael I Schimerlik; John M Pezzuto; Richard B van Breemen
Journal:  Anal Chem       Date:  2007-11-13       Impact factor: 6.986

8.  Identification of a vitamin D responsive element in the promoter of the rat cytochrome P450(24) gene.

Authors:  C N Hahn; D M Kerry; J L Omdahl; B K May
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

9.  The chicken retinoid-X-receptor-gamma gene gives rise to two distinct species of mRNA with different patterns of expression.

Authors:  E A Seleiro; D Darling; P M Brickell
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

10.  Physical mapping of the retinoid X receptor B gene in mouse and human.

Authors:  T Nagata; E H Weiss; K Abe; K Kitagawa; A Ando; Y Yara-Kikuti; M F Seldin; K Ozato; H Inoko; M Taketo
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.